polymorphisms such as GLP1R rs6923761 and GIPR rs1800437 have been examined for their relationship to receptor expression and signaling efficiency
They found that for FDA approved GLP-1s for weight loss, liraglutide (Saxenda) and semaglutide (Wegovy), the percent of side effects reported was as follows: Nausea: 42.2% Diarrhea: 21.9% Vomiting: also 21.9% Constipation: 8.4% They report that although the incidence of side effects were similar among medications, semaglutide had the greatest risk of nausea, diarrhea, and vomiting, whereas liraglutide had the greatest risk of upper abdominal pain
Yes, youve already been on a GLP-1 medication, but tirzepatide works on two receptors instead of one, so your body needs time to get used to it
GLP-3 (Retatrutide) Retatrutide is a multi-receptor peptide examined in human research for its role in metabolic hormone signaling, including glucose regulation, appetite signaling, energy balance, and blood glucose communication
There was a dose-response reduction in liver fat from baseline at 24 weeks with increasing retatrutide doses: -82.4% with 12 mg retatrutide vs
In the same vein, competitor Hims & Hers acquired microneedle diagnostics company YourBio Health to advance longevity and life stage medicine
